For most nonpregnant adults with diabetes, the standard A1C target is below 7%, a threshold endorsed by the American Diabetes Association and supported by decades of outcomes research. But that single number obscures a more nuanced reality: recommended targets shift depending on your age, how long you’ve had diabetes, whether you’re pregnant, and what other health conditions you’re managing. A 30-year-old newly diagnosed with type 2 diabetes and a frail 80-year-old on insulin have very different ideal targets, and treating them the same can cause real harm.
The Standard Adult Target and Where It Comes From
The widely cited goal of an A1C below 7% applies to many nonpregnant adults and reflects a balance between preventing long-term complications and avoiding the dangers of pushing blood sugar too low.1Diabetes Care. 6. Glycemic Targets: Standards of Medical Care in Diabetes—2022 That number corresponds to an estimated average blood glucose of roughly 154 mg/dL. The logic is straightforward: keeping A1C at or below this level substantially reduces the risk of damage to the eyes, kidneys, and nerves over time. Major trials established this connection years ago, and the threshold has remained remarkably stable as a general guideline.
The American College of Physicians, however, has taken a slightly different position, recommending that clinicians aim for an A1C between 7% and 8% in most patients with type 2 diabetes and consider pulling back on medications if A1C dips below 6.5%.2PubMed. Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians This isn’t a contradiction so much as a difference in emphasis. The ACP is weighing the real-world risk that aggressive medication regimens create hypoglycemia, side effects, and treatment burden that can outweigh the marginal benefit of squeezing A1C a few tenths of a point lower. Both organizations agree that the right target depends on the individual.
Why Pushing Too Low Can Be Dangerous
The clearest cautionary evidence comes from the ACCORD trial, which enrolled more than 10,000 adults with type 2 diabetes and high cardiovascular risk. One group was treated intensively, targeting near-normal A1C levels (below 6%), while the other aimed for a more conventional target. The intensive-therapy group experienced more deaths from any cause, with a hazard ratio of about 1.2 compared to the standard group, and the intensive arm was stopped early because of this excess mortality.3PubMed. Long-term effects of intensive glucose lowering on cardiovascular outcomes The intensive approach did produce fewer nonfatal heart attacks, but that benefit was overshadowed by the increased death rate.
ACCORD changed how diabetes specialists think about targets. It demonstrated that an A1C number on paper doesn’t exist in a vacuum. How you get there matters. Stacking multiple medications to force blood sugar down aggressively, especially in people who already have cardiovascular disease, can lead to dangerous low blood sugar episodes that carry their own mortality risk. This is why every major guideline now stresses individualization rather than a single universal number.
Targets for Children and Adolescents
The ADA recommends an A1C below 7% for many children with type 1 diabetes, with the understanding that this needs to be personalized. A higher target of below 7.5% may be more appropriate for younger children who can’t recognize or communicate symptoms of low blood sugar, or for families without access to insulin pumps and continuous glucose monitors. In cases involving a history of severe hypoglycemia or serious additional illnesses, targets can be relaxed further to below 8%. On the other end, during the “honeymoon” period shortly after diagnosis, when the pancreas is still producing some insulin, an A1C below 6.5% may be safely achievable.4Diabetes Care. The Evolution of Hemoglobin A1c Targets for Youth With Type 1 Diabetes: Rationale and Supporting Evidence
Teenagers face a distinct biological challenge. Puberty triggers a sharp drop in insulin sensitivity, comparable in magnitude to the insulin resistance seen during pregnancy.5PubMed. Insulin Resistance of Puberty Classic research found that insulin-stimulated glucose metabolism in pubertal children was roughly 25 to 30 percent lower than in prepubertal children or adults, driven largely by growth hormone surges during puberty.6PubMed. Impaired insulin action in puberty: A contributing factor to poor glycemic control in adolescents with diabetes This means that an adolescent with type 1 diabetes may see their A1C climb during puberty despite their best efforts. Lean body mass roughly doubles over puberty, increasing insulin requirements, and excessive growth hormone secretion further disrupts glucose control.7PubMed Central. Puberty and type 1 diabetes
For parents and teenagers, the practical takeaway is that a rising A1C during mid-puberty does not necessarily mean someone is doing something wrong. Insulin doses often need to increase substantially during these years, and it’s a period where frequent adjustments and close monitoring matter more than hitting a rigid number.
Younger Adults and the Legacy Effect
If you’re diagnosed with type 2 diabetes in your 30s, 40s, or 50s and are otherwise healthy, the evidence strongly favors tighter A1C control early on. A large observational study found that patients whose A1C stayed at or above 6.5% during the first year after diagnosis faced a greater risk of diabetic complications down the road, compared to those who achieved lower levels early. A1C levels at or above 7% in that first year were linked to higher long-term mortality, and longer stretches spent above 8% were associated with progressively higher rates of microvascular damage and death.8PubMed Central. The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications
Researchers call this the “legacy effect” or “metabolic memory.” The glucose exposure your body experiences in the first years after diagnosis seems to leave a lasting imprint on blood vessel and organ health. Even if you bring A1C down later, you can’t fully erase the damage from years of poor control at the start. This finding underscores the urgency of early diagnosis and aggressive treatment for younger adults who have decades of life ahead. For this group, an A1C target below 7%, and possibly below 6.5% if it can be achieved without frequent low blood sugar episodes, is well supported.
Targets for Older Adults
Diabetes management in older adults is where the “it depends” answer gets most complex. The 2025 ADA Standards of Care break older adults into categories based on overall health. Those who are otherwise healthy with few chronic conditions and intact cognitive function should still aim for an A1C of roughly 7% to 7.5%.9Diabetes Care. 13. Older Adults: Standards of Care in Diabetes—2025 The reasoning is that these individuals still have years of life in which complications can develop and worsen quality of life.
For older adults with multiple chronic illnesses, cognitive impairment, or functional limitations, the target shifts upward. An A1C of 7.5% to 8% is often appropriate, and for those who are frail, have limited life expectancy, or live in long-term care settings, an A1C below 8% to 8.5% may be the right balance. Expert consensus statements on diabetes and frailty note that over-treatment is surprisingly common among older adults, with many still on regimens that were intensified years ago when they were healthier or during hospital stays when blood sugar was temporarily elevated.10PubMed Central. Diabetes and Frailty: An Expert Consensus Statement on the Management of Older Adults with Type 2 Diabetes Simplifying and de-escalating medication, especially drugs that can cause low blood sugar like sulfonylureas and certain insulins, becomes a priority as frailty increases.
Why Hypoglycemia Is Especially Risky After 65
The reason guidelines loosen A1C targets for older adults isn’t that high blood sugar stops being harmful. It’s that low blood sugar becomes disproportionately dangerous. In a controlled study comparing older and middle-aged adults with type 2 diabetes, older patients showed a striking inability to recognize when their blood sugar was dropping. During induced low blood sugar, seven of the middle-aged participants correctly identified that their glucose was dangerously low, while only one older participant did.11PubMed Central. Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes The older patients didn’t show the usual warning symptoms like shaking, sweating, and rapid heartbeat that normally alert someone that blood sugar is falling.
Among older adults with type 1 diabetes, the picture is similar. In one study, only 11% of those who had experienced severe hypoglycemia reported always having warning symptoms, compared with 43% of controls.12Diabetes Care. Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes The combination of not sensing low blood sugar and having diminished cognitive reserves to respond to it means that aggressive A1C targets in this population can lead to falls, confusion, cardiac events, and emergency hospitalizations. When your doctor relaxes your A1C target as you age, it’s a deliberate protective measure, not a sign of giving up.
Pregnancy Targets
Pregnancy flips the typical target conversation. Because high blood sugar during pregnancy raises the risk of birth defects, preeclampsia, excessive fetal growth, and other complications, the recommended A1C target is tighter than at any other time: below 6%, provided this can be achieved without significant hypoglycemia.13Diabetes Care. Management of Diabetes in Pregnancy This applies to women who had diabetes before pregnancy, not gestational diabetes, which is managed primarily through post-meal glucose checks rather than A1C.
Research has shown that maintaining strict glycemic control throughout pregnancy, with a late-pregnancy A1C target below 6.5%, leads to reduced rates of both obstetric and neonatal complications regardless of how well controlled blood sugar was in early pregnancy.14PubMed. The use of longitudinal hemoglobin A1c values to predict adverse obstetric and neonatal outcomes in pregnancies complicated by pregestational diabetes There is also a physiological quirk that matters: pregnancy naturally accelerates red blood cell turnover, which tends to lower A1C readings even if blood sugar hasn’t changed. This means an A1C of 6.2% during pregnancy may correspond to a higher actual average glucose than the same reading outside of pregnancy.
Kidney Disease and Other Comorbidities
Chronic kidney disease deserves specific mention because it affects both the A1C target and how reliably A1C reflects actual blood sugar. Higher A1C targets are generally recommended for people with kidney disease, given their elevated risk of hypoglycemia and shortened life expectancy compared to those without kidney involvement.15PubMed Central. Management of diabetes mellitus in patients with chronic kidney disease But there’s a measurement problem as well: advanced kidney disease alters red blood cell lifespan and can cause anemia, both of which distort A1C readings in ways that make the number unreliable as a guide to average glucose.
Any condition that changes how long your red blood cells survive will affect your A1C. The hemoglobin in red blood cells accumulates glucose as the cells circulate, so if cells die faster than normal, there’s less time for glycation and A1C reads artificially low. If cells live longer than normal, A1C reads artificially high. A study using biotin-labeled red blood cells found that the mean age of circulating red blood cells ranged from 39 to 56 days in people with diabetes and 38 to 60 days in controls. That variation was large enough to cause clinically meaningful differences in A1C for any given average blood glucose.16PubMed Central. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c Conditions like iron-deficiency anemia, sickle cell trait, thalassemia, recent blood transfusions, and even certain medications can shift A1C in either direction.17PubMed Central. Pitfalls in hemoglobin A1c measurement: when results may be misleading
Racial and Ethnic Differences in A1C
A1C does not mean the same thing for everyone, and this goes beyond individual variation. Across two large study populations, Black participants had A1C levels that were about 0.4 percentage points higher than white participants at the same average blood glucose level.18PubMed. Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels This gap persisted even after adjusting for fasting glucose, body weight, and other factors that influence A1C. An earlier cross-sectional analysis found similar results: the racial difference widened at higher glucose levels, reaching nearly half a percentage point in people with diabetes.19PubMed. Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies
Data from the Diabetes Prevention Program showed higher A1C levels among several racial and ethnic minority groups with impaired glucose tolerance, even after controlling for factors that affect blood sugar. The researchers concluded that A1C may not be a valid tool for comparing glycemic control across racial and ethnic groups.20PubMed Central. Differences in A1C by Race and Ethnicity Among Patients With Impaired Glucose Tolerance in the Diabetes Prevention Program The biological reasons are not fully settled but likely involve differences in red blood cell characteristics that affect how hemoglobin binds glucose, rather than differences in actual blood sugar levels. For patients and clinicians, this means that a Black patient with an A1C of 7.2% may actually have the same average blood glucose as a white patient with an A1C of 6.8%. Using rigid numerical cutoffs without accounting for this can lead to overdiagnosis, overtreatment, or a false sense of security, depending on who is being measured and in which direction the bias runs.
Beyond A1C: Glycemic Variability and Time in Range
A1C is an average, and averages can hide a lot. Two people with identical A1C readings of 7% could have very different daily glucose patterns. One might have relatively stable blood sugar hovering around 154 mg/dL. The other might swing between 50 and 300 mg/dL multiple times a day and still average out to the same A1C. Those two situations carry very different health risks.
Research has increasingly shown that glycemic variability, the extent of blood sugar swings, is an independent predictor of cardiovascular complications beyond what A1C alone captures.21BMJ Open Diabetes Research & Care. Glycemic variability and cardiovascular disease in patients with type 2 diabetes One study found that long-term variability in fasting blood sugar was a better predictor of major cardiovascular events than A1C itself, with higher variability carrying about a 60% increased risk of events like heart attack and cardiovascular death.22PubMed Central. Clinical implications and pharmacological considerations of glycemic variability in patients with type 2 diabetes mellitus
This is where continuous glucose monitors have changed the conversation. Time in range, which measures the percentage of the day that blood sugar stays between 70 and 180 mg/dL, provides information that A1C simply cannot. A general target of about 70% time in range corresponds roughly to an A1C of 7%, but it also captures stability and helps identify dangerous lows and spikes. An emerging consensus treats time in range as a clinically important endpoint alongside A1C, not a replacement for it.23PubMed Central. Time in range—A new gold standard in type 2 diabetes research?
When Your A1C Doesn’t Match Your Meter Readings
If you’ve ever felt that your A1C result didn’t match what your home glucose meter or continuous monitor was telling you, the disconnect may be real and not just a matter of testing at the wrong times. A 2024 analysis modeled the nonglycemic factors that influence A1C, primarily differences in red blood cell lifespan, and found that for someone with a true A1C of 7%, the estimated average glucose could scatter across a range from about 125 to 183 mg/dL purely due to individual variation in red blood cell survival.24Diabetes Care. Estimating Glycemia From HbA1c and CGM: Analysis of Accuracy and Sources of Discrepancy That’s a gap wide enough to change clinical decisions.
The mechanism is straightforward: hemoglobin picks up glucose gradually over the lifespan of a red blood cell. If your red blood cells happen to live a bit longer than average, more glucose accumulates and your A1C reads higher than your actual average glucose would suggest. The reverse happens if your red blood cells turn over faster than typical.25PubMed Central. The influence of shorter red blood cell lifespan on the rate of HbA1c target achieved in type 2 diabetes patients with a HbA1c detection value lower than 7% This isn’t a flaw that can be fixed by better lab equipment; it’s inherent to what A1C measures. If your readings consistently seem mismatched, it’s worth discussing with your doctor whether fructosamine, glycated albumin, or continuous glucose monitoring data might give a more accurate picture of your glucose control than A1C alone.
A Quick Reference by Age and Situation
Because the targets are scattered across multiple guideline documents, here’s how they generally break down:
- Children (type 1): Below 7% for most; below 7.5% for those unable to recognize low blood sugar or without access to advanced technology; below 8% when severe hypoglycemia or other serious conditions are a concern.
- Adolescents: Same targets as other children, but puberty-driven insulin resistance often makes these harder to hit. A rising A1C during mid-puberty doesn’t automatically mean management has failed.
- Younger and middle-aged adults: Below 7% for most, and possibly below 6.5% early after diagnosis if achievable without frequent lows.
- Healthy older adults: Below 7% to 7.5%.
- Older adults with multiple conditions or cognitive decline: Below 8%, with medication simplification as frailty increases.
- Pregnancy (preexisting diabetes): Below 6% if possible without significant hypoglycemia.
- Chronic kidney disease: Individualized, generally more relaxed, and interpreted cautiously because the A1C reading itself may be unreliable.
These are starting points. Individual factors such as how long someone has had diabetes, which medications they’re on, their risk of falls, their daily routines, and even their personal priorities all feed into the conversation. A person who lives alone without a reliable way to get help during a severe low blood sugar episode will have different safe limits than someone with a partner who can assist. A person who values tight control and is willing to monitor closely may be a good candidate for tighter targets, while someone dealing with treatment fatigue may benefit from a more relaxed approach that still prevents the worst outcomes.2PubMed. Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians